Physician profile
Anna Verde
NPI 1669897435
$2,189.80
in general payments reported to CMS, 2019-2025
19 companies · $63.50 in 2025
The $63.50 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $521 · 2022: $619 · 2023: $724 · 2024: $262 · 2025: $63.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966 · Education: $83.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.20 |
| Education | $83.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $484.84 | 2021-2023 | Dupixent |
| Genzyme Corporation | $330.14 | 2021-2024 | |
| Astrazeneca Pharmaceuticals Lp | $302.04 | 2022-2024 | Breztri, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $233.22 | 2021-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $164.97 | 2021-2022 | |
| Grifols USA, LLC | $133.28 | 2022-2025 | Xembify |
| Csl Behring | $98.36 | 2023-2025 | Hizentra |
| Octapharma USA, INC. | $97.04 | 2021-2023 | Cutaquig |
| Takeda Pharmaceuticals U.S.A., INC. | $77.60 | 2021-2023 | Cuvitru |
| Aimmune Therapeutics, INC. | $44.72 | 2022 | |
| Bio Products Laboratory USA, INC. | $43.50 | 2021-2023 | Gammaplex, Coagadex |
| Tersera Therapeutics LLC | $42.65 | 2023 | Quzyttir |
| Pfizer INC. | $23.53 | 2022 | |
| Genentech USA, INC. | $22.16 | 2024 | Xolair |
| Hikma Pharmaceuticals USA | $20.83 | 2023 | Ryaltris |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $20.41 | 2021 | |
| Abbvie INC. | $17.42 | 2025 | |
| Alk-Abello, INC | $17.36 | 2023 | Grastek, Odactra |
| Kaleo, INC. | $15.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Verde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.